The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - a multicenter prospective trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples